It is often uncertain whether a repeat biopsy is necessary in patients with at least one previous negative prostate biopsy but persistent suspicion of prostate cancer. Here we present the use of multi-parametric magnetic resonance imaging (mp-MRI) to successfully detect and localize a prostate cancer and we suggest that MRI can be useful in optimising repeat biopsy procedures of the prostate in...

W hat is the optimal biopsy strategy for detecting clinically important prostate carcinoma? I am not sure we are any closer in 2007 than we were in 1989 when the 6-core biopsy technique became the standard of care. Take too few cores and clinically significant cancers might be missed. However, take too many cores and clinically indolent cancer may be identified. Data from the early 1990s demons...

Abstract Introduction LIKERT 4 and 5 lesions picked up on MRI prostate have a high chance of picking grade volume cancer so they under biopsy. It is quite challenging to decide whether biopsy pure 3 lesions. In our retrospective review 500 scan we looked for correlation between the risk finding after Materials Methods Pre-biopsy Multi parametric was done in cases reported by two consultant radi...

IMPORTANCE Despite ongoing controversies surrounding prostate-specific antigen (PSA) screening, many men 65 years or older undergo screening. However, few data exist that quantify the chain of events following screening in clinical practice to better inform decisions. OBJECTIVE To quantify 5-year downstream outcomes following a PSA screening result exceeding 4.0 ng/mL in older men. DESIGN A...

OBJECTIVES The aim of this study is to determine the utility of transrectal real-time elastography (TRTE)-guided prostate biopsies in patients subjected to transrectal ultrasound (TRUS)-guided transperineal prostate biopsies. MATERIALS AND METHODS A total of 108 consecutive patients suspicious for prostate cancer (PCa) with elevated serum prostate specific antigen (PSA) level > 4 μg/L or abno...

In 2016, it is estimated 180,890 men are newly diagnosed with prostate cancer and 3,306,760 men live with prostate cancer in the United States. The introduction of multiparametric (mp) magnetic resonance imaging (MRI) of the prostate, standardised interpretation guidelines such as Prostate Imaging Reporting and Data System (PI-RADS version 2), and MRI-based targeted biopsy has improved detectio...

Background. Common antibiotic prophylactic strategies for prostate biopsy may be insufficient to prevent procedure-associated sepsis, particularly with the rise of Gram-negative pathogens that are resistant to fluoroquinolones. We aim to describe all-cause and infection-related readmission rates and costs in a national sample of men undergoing prostate biopsy. Methods. We compared mean rates of...

Introduction and objective: Discordant data still persists regarding the optimal prostate biopsy scheme to be used, the correct timing for performing repeat biopsy in high risk patients as well as the ability of clinical variables to predict prostate cancer. The aim of this review is to provide a comprehensive assessment of different prostate biopsy approaches and to evaluate the role of clinic...

PURPOSE To retrospectively evaluate the effect of post-prostate-biopsy hemorrhage on the interpretation of magnetic resonance diffusion-weighted (MRDW) and magnetic resonance spectroscopic (MRS) imaging in the detection of prostate cancer. We also investigated the optimal timing for magnetic resonance examination after prostate biopsy. MATERIALS AND METHODS We reviewed the records of 135 men....

PURPOSE To investigate the incidence, clinical features, pathogenic bacteria, and risk factors associated with acute prostatitis after transrectal prostate biopsy. MATERIALS AND METHODS We retrospectively reviewed the medical records of 923 transrectal ultrasound-guided needle biopsies of the prostate in 878 patients performed at our institution from June 2004 to May 2009. The indications for...